Skip to main content Accessibility help
×
Home
  • Print publication year: 2017
  • Online publication date: June 2017

Chapter 18 - Urogynaecology

Related content

Powered by UNSILO
1.National Institute for Health and Clinical Excellence. Urinary Incontinence in Women: Management. December, 2014. [https://www.nice.org.uk/guidance/cg190]
2.National Institute of Clinical Excellence. Mirabegron for Treating Symptoms of Overactive Bladder. Technology Appraisal Guidance. June, 2013. [https://www.nice.org.uk/guidance/ta290]
3.Barnes, DG, Shaw, PJ, Timoney, AG, Tsokos, N. Management of the neuropathic bladder by suprapubic catheterisation. Br J Urol 1993;72:169–72.
4.Hussain, U, Kearney, R. Surgical management of stress urinary incontinence. Obstet Gynaecol Reprod Med 2013;23(4):108–13.
5.The Royal College of Obstetricians and Gynaecologists. Post-Hysterectomy Vaginal Vault Prolapse. July, 2015. [https://www.rcog.org.uk/ guidelines-research-services/guidelines/gtg46]
6.Freeman, RM, Pantazis, K, Thomson, A, et al. A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. Int Urogynecol J 2013;24:377–84.
7.Cox, S, Reid, F. Urogynaecological complications in pregnancy: an overview. Obstet Gynaecol Reprod Med 2015;25(5):123–7.
8.Swithinbank, LV, Watson, A. Basic understanding of urodynamics. Obstet Gynaecol Reprod Med 2015;25(11):321–6.
9.Bump, RC, Mattiasson, A, , K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:1017.